Ex-Obamacare Chief Warns Trump’s Already Weakening The Health Care System

http://www.huffingtonpost.com/entry/ex-obamacare-chief-warns-trumps-already-weakening-the-health-care-system_us_588bca30e4b0b065cbbc071b?utm_source=&utm_medium=email&utm_campaign=5982

Image result for Ex-Obamacare Chief Warns Trump Already Weakening The Healthcare System

Andy Slavitt helped save Obamacare once already. He’s hoping he can do it again.

Until Inauguration Day, Slavitt had been acting administrator of the Centers for Medicare and Medicaid Services since March 2015. That agency oversees the two health programs in its name along with the Children’s Health Insurance Program and the Affordable Care Act’s health insurance exchanges. CMS, as it’s known, manages benefits for 140 million people and its $1 trillion budget is bigger than the Pentagon’s.

In the short time since Slavitt left federal service, he’s already seeing signs that President Donald Trump and the GOP Congress are dealing damage to the health care system before even repealing the Affordable Care Act. And health care executives are telling him the same thing, Slavitt said.

The Affordable Care Act first entered Slavitt’s life in the fall of 2013, when he helped lead the effort to salvage HealthCare.gov, the federal insurance exchange website, after its disastrous launch. From there, Slavitt left his position as group executive president of Optum, a unit of UnitedHealth Group, to join CMS as a senior official. President Barack Obama nominated Slavitt for the top job in July 2015 but the Senate never held a vote on him.

Now Slavitt is out of government, but he’s not abandoning the fight over the Affordable Care Act. In an interview with The Huffington Post, he argued that Trump is already undermining the law and threatening coverage for millions ― in spite of his repeated promises to ensure that all Americans would have health care under his policies.

“I take the new president at his word. He said he wants to expand coverage. He said he wants the coverage to be high-quality. He said he wants it to be affordable to Americans who have trouble affording health care,” Slavitt said. “Those are the right goals, and I think the president should start out with those goals. Now, the actions that we’ve seen so far don’t support those goals.”

Specifically, Slavitt cited the executive order Trump issued the day of his inauguration, which instructs federal agencies to “take all actions consistent with law to minimize the unwarranted economic and regulatory burdens of the Act, and prepare to afford the States more flexibility and control to create a more free and open healthcare market.”

The White House subsequently signaled this could include halting enforcement of the law’s individual mandate that most Americans obtain health coverage.

Executive actions such as these, and like the Trump administration halting television advertising for the sign-up period that ends Tuesday, threaten to destabilize the health insurance market, Slavitt. These moves signal to health insurers that enrollment will be lower this year than it could have been, and that fewer of the healthy consumers needed to offset the costs of the sick will buy coverage. Without the mandate’s tax penalty for being uninsured, some consumers will opt against buying insurance.

“It increases premiums, it will send people out of the market,” Slavitt said. “Those actions that we’ve seen haven’t gotten us on the track that we would hope and that we need to be on in a bipartisan fashion, and so I’d hope that they’re quickly corrected.”

Koch-backed group details hopes for healthcare reform

http://thehill.com/policy/healthcare/316875-koch-backed-group-pushes-for-high-risk-pools-medicaid-freeze-in-obamacare

Koch-backed group details hopes for healthcare reform

A conservative group funded by the Koch brothers is pushing for high-risk pools and a freeze on Medicaid expansions as lawmakers try to coalesce around a replacement for ObamaCare.

Freedom Partners began circulating a memo on Capitol Hill Monday with specific reforms it thinks lawmakers should pass, including: the creation of high-risk pools at the state level to cover people with pre-existing conditions; the elimination of the ObamaCare mandate, which required everyone buy insurance or pay a penalty; and the expansion of access to health savings accounts, so people can save and pay for healthcare with pre-tax dollars.

The recommendations fall in line with what top Republicans in Congress have indicated they support.

High-risk pools offer coverage for sick people that otherwise could be denied coverage for having pre-existing conditions if ObamaCare is repealed.

Drug Makers Accused of Fixing Prices on Insulin

A lawsuit filed Monday accused three makers of insulin of conspiring to drive up the prices of their lifesaving drugs, harming patients who were being asked to pay for a growing share of their drug bills.

The price of insulin has skyrocketed in recent years, with the three manufacturers — Sanofi, Novo Nordisk and Eli Lilly — raising the list prices of their products in near lock step, prompting outcry from patient groups and doctors who have pointed out that the rising prices appear to have little to do with increased production costs.

The lawsuit, filed in federal court in Massachusetts, accuses the companies of exploiting the country’s opaque drug-pricing system in a way that benefits themselves and the intermediaries known as pharmacy benefit managers. It cites several examples of patients with diabetes who, unable to afford their insulin treatments, which can cost up to $900 a month, have resorted to injecting themselves with expired insulin or starving themselves to control their blood sugar. Some patients, the lawsuit said, intentionally allowed themselves to slip into diabetic ketoacidosis — a blood syndrome that can be fatal — to get insulin from hospital emergency rooms.

A recent study in The Journal of the American Medical Association found that the price of insulin nearly tripled from 2002 to 2013.

“People who have to pay out of pocket for insulin are paying enormous prices when they shouldn’t be,” said Steve Berman, a lawyer whose firm filed the suit on behalf of patients and is seeking to have it certified as a class action.

In a statement, Sanofi said, “We strongly believe these allegations have no merit, and will defend against these claims.” Lilly said it had followed all laws, adding, “We adhere to the highest ethical standards.”

A spokesman for Novo Nordisk said the company disagreed with the allegations in the suit and would defend itself. “At Novo Nordisk,” the company’s statement said, “we have a longstanding commitment to supporting patients’ access to our medicines.”

The rising costs of drugs has led to several hearings in Congress and has drawn the attention of President Trump, who this month pledged to address the issue and said the industry was “getting away with murder.”

 

Asking the Right Questions: Why Healthcare Predictive Analytics Often Don’t Predict Anything Meaningful at All.

https://www.linkedin.com/pulse/asking-right-questions-why-healthcare-predictive-dont-cousins-phd?trk=v-feed&lipi=urn%3Ali%3Apage%3Ad_flagship3_feed%3BgC0bModjFFl7I4auAFAWBQ%3D%3D

Healthcare organizations collectively waste billions of dollars every year by focusing on the wrong problem to solve. This isn’t unique to healthcare, of course. A recent, must-read article in Harvard Business Review, “Are You Solving the Right Problems” by Thomas Wedell explains how organizations that are good at problem solving often focus on the wrong ones to solve. It’s often human nature.

Healthcare analytics offers a particularly good example. Today, health plans, hospital systems, post-acute care companies and other provider organizations are keenly focused on identifying those patients who are at highest risk of adverse events, such as readmissions and post op complications. They then invest precious resources trying to reduce that risk through home visits, additional pre-op or post-operative care, and so on.

Yet, despite the apparent logic, according to our research, 50% or more of patients identified as high risk cannot be impacted by the interventions provided to reduce that risk.

Yet, despite the apparent logic, according to our research, 50% or more of patients identified as high risk cannot be impacted by the interventions provided to reduce that risk.

On the face of it, this seems like a logical approach to improving care and reducing costs. Yet, despite the apparent logic, according to our research, 50% or more of patients identified as high risk cannot be impacted by the interventions provided to reduce that risk. In some cases, they can’t be impacted at all. Our research is consistent with that conducted by others, including a randomized controlled study of telephone care management and study on nurse-led home-based intervention. In short, a lot of the money spent trying to avoid adverse events is wasted.

https://hbr.org/2017/01/are-you-solving-the-right-problems